Conor Steuer

Emory University

Papers

3

Total Citations

17

H-Index

2

About

Dr. Conor Steuer is a leading oncologist and researcher whose work centers on the molecular drivers of head and neck cancers, with a particular focus on the role of human papillomavirus (HPV) in shaping treatment paradigms. His most impactful contribution, the 2022 paper "HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?" (12 citations), explores how HPV-positive tumors may allow for less aggressive, de-escalated therapies—a critical shift that could reduce long-term toxicity for patients while maintaining survival outcomes. Dr. Steuer also co-authored the "Handbook of Lung Cancer and Other Thoracic Malignancies" (2016, 4 citations), a comprehensive resource that bridges clinical practice and emerging research. His 2022 study on predictive factors for primary treatment in early-stage oropharyngeal squamous cell carcinoma further demonstrates his commitment to personalizing care. With a career dedicated to translating molecular insights into practical, patient-centered strategies, Dr. Steuer is shaping a future where cancer treatment is both more effective and less debilitating.

Research Focus

Key Achievements

2
H-Index
3
Papers
17
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?
12 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: Emory University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago